More delays? Now Roche’s CEO says he’s willing to wait well into next year to complete their $4.3B Spark buyout
Roche CEO Severin Schwan wants the staff at Spark to know that he’s absolutely committed to completing his $4.3 billion deal to buy the gene therapy company. And he’s prepared to wait well into 2020 to get it, if necessary.
Basic subscription required
Unlock this story instantly and join 55,100+ biopharma pros reading Endpoints daily — and it's free.